The Affecting Factors of Compliance Diabetes Mellitus Type 2 Treatment in Pandemic Era

Ratih Puspita Febrinasari(1), Tri Agusti Solikah(2), Dyonisa Nasirochmi(3), Dilma’aarij Dilma’aarij(4),

(1) Fakultas Kedokteran Universitas Sebelas Maret


Diabetes mellitus (DM) is one of the non-communicable diseases that cause serious health problems. This chronic disease requires lifelong treatment to prevent complications and death. In the pandemic era, DM became comorbid that contributed to the death rate in Covid-19 cases, so that patients with type 2 DM become important to comply with the treatment underway. Aim: This study aimed to evaluate the treatment compliance in patients with DM type 2 at the Purwodiningratan primary health care, Surakarta. Method: This study was conducted in 2020 used an analytical method with crosssectional design. Populations were all of the patients who experience DM type 2, sampling techniques used total sampling with 108 respondents. Univariate, bivariate analysis, and logistic regression were used in this study. Compliance levels measured used the MMAS-8 questionnaire. Result:  The results of this study were obtained from several independent variables that related to compliance with DM type 2 treatment. The descriptive analysis result of patient compliance showed that 70.4% of patients were obedient. The significant variable was the side effects on DM drugs with (OR = -0.44; 95% CI = -0.74 - 0.15; p = 0.003). Conclusion: Most of the patients were adherent to the treatment and the most influencing factor was the side effect of the drug.


treatment compliance; diabetes mellitus type 2; pandemic era

Full Text:



Ali, I., 2021. Syndemics at Play: Chronic Kidney Disease, Diabetes and COVID-19 in Pakistan. Annals of Medicine, 53(1), pp.581–586.

American Diabetes Association., 2019. Standards of Medical Care in Diabetes – 2019. The Journal of Clinical and Applied Research and Education, 42(1), pp.S13-28.

Aminde, L.N., Tindong, M., Ngwasiri, C.A., Aminde, J.A., Njim, T., Fondong, A.A., & Takah, N.F., 2019. Adherence to Antidiabetic Medication and Factors Associated with Non-adherence Among Patients with Type-2 Diabetes Mellitus in Two Regional Hospitals in Cameroon. BMC Endocrine Disorders, 19(1).

Badan Penelitian dan Pengembangan Kesehatan., 2019. Laporan Provinsi Jawa Tengah RISKESDAS 2018. Jakarta.

Chou, Y.C., Yen, Y.F., Feng, R.C., Wu, M.P., Lee, Y.L., Chu, D., Huang, S.J., Curtis, J.R., & Hu, H.Y., 2020. Impact of the COVID-19 Pandemic on the Utilization of Hospice Care Services: A Cohort Study in Taiwan. Journal of Pain and Symptom Management, 60(3), pp. e1–e6.

Hartmann-Boyce, J., Morris, E., Goyder, C., Kinton, J., Perring, J., Nunan, D., Mahtani, K., Buse, J.B., Prato, S.D., Ji, L., Roussel, R., & Khunti, K., 2020. Diabetes and COVID-19: Risks, Management, and Learnings from Other National Disasters. Journal Diabetes Care, 43(8), pp.1695–1703.

Huang, I., Lim, M.A., & Pranata, R., 2020. Since January 2020 Elsevier has Created a COVID-19 Resource Centre with Free Information in English and Mandarin on the Novel Coronavirus COVID- 19. Annals of Medicine Journal. 53(1), pp.581-586.

International Diabetes Federation., 2019. IDF Diabetes Atlas 9th Edition.

Michalakis, K., & Ilias, I., 2021. COVID-19 and Hyperglycemia/Diabetes. Word Journal Diabetes, 12(5), pp.642–650.

Mukona, D.M., & Z, M., 2020. Elsevier has Created a COVID-19 Resource Centre with Free Information in English and Mandarin on the Novel Coronavirus COVID- 19. Diabetes Metab Syndr Clin Res Rev., 14(1), pp.1575–8.

Mulyawati, I., 2015 Obesitas Sentral Dan Kadar Kolesterol Darah Total. Jurnal Kesehatan Masyarakat, 11(1), pp. 87–95.

Nogueira, M., Otuyama, L.J., Rocha, P.A., & Pinto, V.B., 2020. Pharmaceutical Care-based Interventions in Type 2 Diabetes Mellitus : A Systematic Review and Meta-analysis of Randomized Clinical Trials. Einstein (Sao Paulo, Brazil), 18(1), pp.1-14.

Polonsky, W.H., & Henry, R.R., 2016. Poor Medication Adherence in Type 2 Diabetes: Recognizing the Scope of the Problem and Its Key Contributors. Dovepress, 10(6), pp.1299–1307.

Pugliese, G., Vitale, M., Resi, V., & Orsi, E., 2020. Is Diabetes Mellitus a Risk Factor for CoronaVirus Disease 19 (COVID-19). Acta Diabetologica. Springer Milan, 57(11), pp.1275–1285.

Putra, R.J.S., Achmad, A., & Rachma P.H., 2017. Kejadian Efek Samping Potensial Terapi Obat Anti Diabetes Pada Pasien Diabetes Melitus Berdasarkan Algoritme Naranjo. Pharmaceutical Journal of Indonesia, 2(2), pp.45–50.

Saheb-Kashaf, M., McGill, E.T., & Berger, Z.D., 2017. Shared Decision-making and Outcomes in Type 2 Diabetes: A Systematic Review and Meta-analysis. Patient Education and Counseling, 100(12), pp.2159–2171.

Sayeed, K.A., Qayyum, A., Jamshed, F., Gill, U., Usama, S.M., Asghar, K., & Tahir, A., 2020. Impact of Diabetes-related Self-management on Glycemic Control in Type II Diabetes Mellitus. Cureus, 12(4).

Sofiana, L., & Rahmawati, D.D., 2019. Hypertension and Diabetes Mellitus Increase the Risk of Stroke. Jurnal Kesehatan Masyarakat, 15(2), pp.147–152.

Umano, G.R., Sessa, A.D., Guarino, S., Gaudino, G., Marzuillo, P., & Giudice, E.M-d., 2021. Telemedicine In The Covid-19 Era: Taking Care Of Children With Obesity And Diabetes Mellitus. Word Journal of Diabetes, 12(5), pp.651–657.

Welch, G., Allen, N.A., Zagarins, S.E., Stamp, K.D., Bursell, S.E., Kedziora, R.J., 2011. Comprehensive Diabetes Management Program for Poorly Controlled Hispanic Type 2 Patients at a Community Health Center. The Diabetes Educator, 37(5), pp.680–688.


  • There are currently no refbacks.

Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.